Targeting STAT3 in cancer immunotherapy

S Zou, Q Tong, B Liu, W Huang, Y Tian, X Fu - Molecular cancer, 2020 - Springer
As a point of convergence for numerous oncogenic signaling pathways, signal transducer
and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune …

Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation

J Dong, XD Cheng, WD Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates various biological processes, including proliferation, metastasis, angiogenesis …

Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions

M El-Tanani, AO Al Khatib, SM Aladwan, A Abuelhana… - Cellular …, 2022 - Elsevier
Abstract The Signal Transducer and Activator of Transcription 3 (STAT3) protein is encoded
on chromosome 17q21. The SH2 and the DNA binding domains are critical structural …

Focus on formononetin: anticancer potential and molecular targets

SKL Ong, MK Shanmugam, L Fan, SE Fraser, F Arfuso… - Cancers, 2019 - mdpi.com
Formononetin, an isoflavone, is extracted from various medicinal plants and herbs, including
the red clover (Trifolium pratense) and Chinese medicinal plant Astragalus membranaceus …

The role of bioactive compounds in natural products extracted from plants in cancer treatment and their mechanisms related to anticancer effects

M Yuan, G Zhang, W Bai, X Han, C Li… - Oxidative Medicine and …, 2022 - Wiley Online Library
Cancer is one of the greatest causes of death worldwide. With the development of surgery,
radiotherapy, and medical agents, the outcomes of cancer patients have greatly improved …

[HTML][HTML] RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC

SJ Kim, JS Ju, MH Kang, JE Won, YH Kim… - Theranostics, 2020 - ncbi.nlm.nih.gov
Breast cancer (BC) is one of the most common cancers in women. TNBC (Triple-negative
breast cancer) has limited treatment options and still lacks viable molecular targets, leading …

The role of STAT3/p53 and PI3K-Akt-mTOR signaling pathway on DEHP-induced reproductive toxicity in pubertal male rat

G Fu, J Dai, Z Li, F Chen, L Liu, L Yi, Z Teng… - Toxicology and Applied …, 2020 - Elsevier
Abstract Di (2-ethylhexyl) phthalate (DEHP) is a known environmental endocrine disruptor
that impairs development of testis and spermatogenesis. This study aims to explore the …

Furazans in medicinal chemistry

RS Mancini, CJ Barden, DF Weaver… - Journal of Medicinal …, 2021 - ACS Publications
Incorporation of heterocycles into drug molecules can enhance physical properties and
biological activity. A variety of heterocyclic groups is available to medicinal chemists, many …

Exploitation of proximity-mediated effects in drug discovery: an update of recent research highlights in perturbing pathogenic proteins and correlated issues

C Zhao, H Wang, W Zhan, X Lv… - Journal of Medicinal …, 2023 - ACS Publications
The utilization of proximity-mediated effects to perturb pathogenic proteins of interest (POIs)
has emerged as a powerful strategic alternative to conventional drug design approaches …

Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin

Y Wang, Z Cheng, J Xu, M Lai, L Liu, M Zuo… - …, 2021 - Taylor & Francis
Excessive activation of signal transducer and activator of transcription 3 (STAT3) is
implicated in breast cancer (BC) chemoresistance, but its underlying mechanism is not fully …